500341-65-1Relevant academic research and scientific papers
FLUOROALKYL-OXADIAZOLES AND USES THEREOF
-
Paragraph 00522-00523, (2021/06/26)
Provided herein are compounds identified as inhibitors of HDAC6 activity that can be used to treat various diseases and disorders.
Selective NK-3 receptor antagonist, preparation and application thereof
-
Paragraph 0201-0205, (2020/11/09)
The invention provides a selective NK-3 receptor antagonist, preparation and application thereof, particularly a compound represented by the following formula (I). The compound of the invention has unexpected activity to modulate cytokines and/or interferon, and is useful in the treatment of CNS and peripheral diseases or disorders.
